Trial Profile
Clinical Study of Apatinib and chemotherapy sequential treatment with advanced metastatic esophageal cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Docetaxel; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 20 Jan 2017 New trial record